Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(3.82) per share. This is a 45.8 percent decrease over losses of $(2.62) per share from the same period last year.
Related Posts
UAW Strike Could Put Auto Suppliers, Michigan Economy In Crisis, Analysts Say
Three of the leading U.S. automotive companies face uncertainties after a contract dispute with the United Auto Workers (UAW) union was not resolved Thursday night.
Earnings Preview For Kemper
Kemper (NYSE:KMPR) is set to give its latest quarterly earnings report on Monday, 2022-08-01. Here's what investors need to know before the announcement.
Analysts estimate that Kemper will report an earnings per share (EPS) of $-0.67.
BridgeBio Pharma Q4 EPS $(0.92) Misses $(0.86) Estimate, Sales $1.87M Miss $5.00M Estimate
BridgeBio Pharma (NASDAQ:BBIO) reported quarterly losses of $(0.92) per share which missed the analyst consensus estimate of $(0.86) by 6.98 percent. This is a 8.91 percent increase over losses of $(1.01) per share from